Pleconaril: Phase III
VPHM announced preliminary Phase III results with Pleconaril, demonstrating shortened duration of headache, the primary
Gathering data...
VPHM announced preliminary Phase III results with Pleconaril, demonstrating shortened duration of headache, the primary